Key Takeaways

Repeat prescriptions are subject to clinical authorisation and regular reviews to ensure safety.
eScript tokens have expiry dates to ensure that medication use is regularly reviewed and controlled.
Pharmacists verify the accuracy and eligibility of each repeat prescription at the point of dispensing.
If a token is missing or expired, patients must use official channels to request a reissue.

Alongside a 'digital by default' framework, the Australian healthcare system saw new regulations governing repeat prescriptions. Although eScripts make life easier, they still have detailed eligibility criteria that safeguard the patient, ensure regulatory compliance, and support clinical oversight. Patients who are familiar with eScript & Prescription Access Hub should fully understand these rules.

Repeat prescriptions require clinical authorisation from your doctor and are not automatically issued. In this guide, you will find an explanation of the eligibility criteria, the importance of GP reviews, and the digital safeguards that ensure your health and privacy are well-protected.

When a GP Review Is Required

One of the main requirements for eligibility for repeat prescriptions is ongoing clinical oversight. A prescription is a formal document that records a doctor's evaluation of your health at a specific time. To keep that permission valid, a reassessment should be conducted regularly.

Clinical Review Intervals

Standard Chronic Care: A formal GP review is generally required for most long-term medications every 6 to 12 months. This session allows the physician to evaluate whether the medication is working and to check for any contraindications that have reappeared.
Complex Conditions: Patients with complex needs should have their care plans reviewed at least every 3 to 6 months, as recommended by the updated GP Chronic Condition Management (GPCCM) framework.
Stable ADHD Management: As of recent reforms, stable ADHD patients (age 6+) may be managed by skilled GPs for repeat prescriptions, provided they are clinically stable.
Non-Emergency Criteria: Telehealth repeat prescription requests should only be used for stable, non-urgent conditions. If there have been changes in symptoms or new side effects, an online GP consultation may be required.

Token Expiry and Reissue Policies

eScripts are digital, and tokens have expiration periods. A repeat is permitted only if the original digital record remains valid.

Why Digital Tokens Expire

Safety Safeguards: Expiry dates (typically 12 months for Schedule 4 and 6 months for Schedule 8) are set within the National Prescription Delivery Service (NPDS) to promote regular clinical oversight and patient safety.
Controlled Access: If a script expires, the token is deactivated in the national cloud. The pharmacy system will not dispense without a valid prescription, even if repeats are available.
The Reissue Process: In case you have misplaced a token, but the script is still valid in the eyes of the law, then you will qualify for a Secure Token Reissue. It is essential to verify identity, but a clinical reassessment may not be necessary if the physician has already approved the supply.

Pharmacy Verification of Repeats

Besides, eligibility is also confirmed at the point of medication dispensing. Pharmacists are the final checkpoint, ensuring that each repeat issued complies with the Therapeutic Goods Act Medicines Regulation 2026.

The Validation Workflow

Scanning the Repeat: Presenting a repeat eScript token enables real-time synchronisation of the pharmacist's software with the PDS. This recognises the lawful intervals between your previous and the new supply.
Identity Match: Pharmacists must verify the eScript by matching the electronic record to the patient's full name and date of birth.
Regulatory Compliance: If a prescriber fails to indicate a mandatory interval for a Schedule 8 medication, repeats are not valid until the record is corrected, resulting in discontinuation of the medication until the record is corrected. This prevents potential misuse and helps maintain higher-quality, more compliant standards.

When Patients Should Request Early Help

Planning helps maintain eligibility and avoid disruptions in care. If you wait until your last tablet is finished, then you may face difficulties, particularly if a review is overdue.

Planning for Continuity

No More Last-Minute Issues: We recommend applying for a telehealth repeat review at least 7 days before your current medication expires. This way, you will have a buffer for booking availability and for the pharmacy to process the prescription.
Interstate Planning: While eScripts offer cross-state prescription flexibility, some high-risk medications are subject to specific state monitoring requirements. Address these with your GP before travelling.

MyMedicare Registration: Patients with chronic conditions are encouraged to register with a 'medical home' through MyMedicare, as this formal connection to their primary care team can make the verification of repeat prescription eligibility smoother